Spotlight On... Mayo Clinic launches initiative to work with Israeli startups; Baxter unveils new class of dialysers to better clear large toxins; BrightWater gets $5.2M to better remove ureteral obstructions; and more...

Mayo Clinic has launched an effort to promote collaborations between itself and Israeli startups. It will be managed by Mayo Clinic Ventures. The Mayo Clinic Israeli Startups Initiative will fund sponsored research and co-development activities among Mayo Clinic and Israeli startups that show innovative and commercial potential. "We are excited to launch this initiative at this premier life sciences global gathering and look forward to advancing the research and development innovations that have high potential to alleviate the burdens of human disease," said Dr. Amir Lerman, medical director of the Mayo Clinic Israeli Startup Initiative and a Mayo Clinic cardiologist, in a statement. More

> Baxter ($BAX) is previewing its Theranova, a new class of dialysers that clear large toxins in addition to the standard small soluates like urea. More

> The FDA has cleared the Third Eye Panoramic colonoscopy device from Avantis Medical Systems as a device that can be used multiple times before disposal; it was already cleared as a disposable device. More

> BrightWater Medical nabs $5.2 million Series A to back its ConvertX Nephroureteral Stent System in gaining U.S. and EU approvals. It's designed to prevent a second procedure to treat severe ureteral obstructions. More

Suggested Articles

Smith+Nephew is contracting with the U.K. government to build a new ventilator specifically designed for large-scale production.

NantWorks’ ImmunityBio has begun a supercomputing collaboration with Microsoft to map out the spike protein of the novel coronavirus.

President Emmanuel Ligner talks about finalizing a multibillion-dollar deal while adjusting and responding to the global COVID-19 crisis.